Efficacy and safety of sunvozertinib in treatment naive NSCLC patients with EGFR exon20 insertion mutations

被引：0

作者：

Xu, Yan

Yang, James Chih-Hsin

Chiu, Chao-Hua

Hsu, Ping-Chih

Mitchell, Paul

Chang, Chia Lun

John, Tom

Bazhenova, Lyudmila

Kim, Tae Min

Yip, Ching Wan

Wang, Mengzhao

Janne, Pasi A.

Zhou, Caicun

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China

[2] Natl Taiwan Univ Hosp, Taipei, Taiwan

[3] Natl Taiwan Univ Canc Ctr, Taipei, Taiwan

[4] Taipei Vet Gen Hosp, Taipei, Taiwan

[5] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan

[6] Austin Hosp, Melbourne, Vic, Australia

[7] Wan Fang Hosp, Taipei, Taiwan

[8] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[9] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA

[10] Seoul Natl Univ Hosp, Seoul, South Korea

[11] Dizal Pharmaceut, Shanghai, Peoples R China

[12] Dana Farber Canc Inst, Boston, MA 02115 USA

[13] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Shanghai, Peoples R China

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9073

引用

页数：1